1.MEI Guoqiang's Experience in Treating Lung Cancer with Modified Xiaoxianxiong Decoction (小陷胸汤)
Shuo HUANG ; Songlin LIU ; Xian ZHOU ; Lesi XU ; Kaizheng ZHAO ; Youlan KE ; Huiyi LU
Journal of Traditional Chinese Medicine 2024;65(17):1753-1756
This article summarized the clinical experience of MEI Guoqiang in treating lung cancer of phlegm-heat obstructed in the lung syndrome with modified Xiaoxianxiong Decoction (小陷胸汤). It is believed that the key pathogenesis of lung cancer with phlegm-heat obstructed in the lung syndrome is the phlegm-heat toxin accumulation. According to the different pathogenic effects of qi stagnation, blood stasis, pathogenic toxin, phlegm-damp, qi deficiency, yin deficiency in the occurrence and development of the disease, it is advocated to clear heat and resolve phlegm, and additionally the methods of diffusing the lung and relieving cough, resolving toxins and dissipating masses, rectifying qi and activating blood, dispelling dampness, supplementing and boosting qi and yin are used if necessary. Multiple methods are used together and flexibly matched. In clinical practice, Xiaoxian-xiong Decoction with the function of clearing heat and relieving phlegm is recommended as the basic formula for further modification. For patients with mild lung symptoms, modified Xiaoxianxiong Decoction is commonly used, while for those with obvious symptoms, self-made Maxing Xianxiong Decoction(麻杏陷胸汤) in modifications is suggested. For patients with Shaoyang (少阳) diseases, modified Chaihu Xianxiong Decoction (柴胡陷胸汤) is often used.
2.Pulmonary rehabilitation restores limb muscle mitochondria and improves the intramuscular metabolic profile
Shiwei QUMU ; Weiliang SUN ; Jing GUO ; Yuting ZHANG ; Lesi CAI ; Chaozeng SI ; Xia XU ; Lulu YANG ; Xuanming SITU ; Tianyi YANG ; Jiaze HE ; Minghui SHI ; Dongyan LIU ; Xiaoxia REN ; Ke HUANG ; Hongtao NIU ; Hong LI ; Chang'An YU ; Yang CHEN ; Ting YANG
Chinese Medical Journal 2023;136(4):461-472
Background::Exercise, as the cornerstone of pulmonary rehabilitation, is recommended to chronic obstructive pulmonary disease (COPD) patients. The underlying molecular basis and metabolic process were not fully elucidated.Methods::Sprague-Dawley rats were classified into five groups: non-COPD/rest ( n = 8), non-COPD/exercise ( n = 7), COPD/rest ( n = 7), COPD/medium exercise ( n = 10), and COPD/intensive exercise ( n = 10). COPD animals were exposed to cigarette smoke and lipopolysaccharide instillation for 90 days, while the non-COPD control animals were exposed to room air. Non-COPD/exercise and COPD/medium exercise animals were trained on a treadmill at a decline of 5° and a speed of 15 m/min while animals in the COPD/intensive exercise group were trained at a decline of 5° and a speed of 18 m/min. After eight weeks of exercise/rest, we used ultrasonography, immunohistochemistry, transmission electron microscopy, oxidative capacity of mitochondria, airflow-assisted desorption electrospray ionization-mass spectrometry imaging (AFADESI-MSI), and transcriptomics analyses to assess rectal femoris (RF). Results::At the end of 90 days, COPD rats’ weight gain was smaller than control by 59.48 ± 15.33 g ( P = 0.0005). The oxidative muscle fibers proportion was lower ( P < 0.0001). At the end of additional eight weeks of exercise/rest, compared to COPD/rest, COPD/medium exercise group showed advantages in weight gain, femoral artery peak flow velocity (Δ58.22 mm/s, 95% CI: 13.85-102.60 mm/s, P = 0.0104), RF diameters (Δ0.16 mm, 95% CI: 0.04-0.28 mm, P = 0.0093), myofibrils diameter (Δ0.06 μm, 95% CI: 0.02-0.10 μm, P = 0.006), oxidative muscle fiber percentage (Δ4.84%, 95% CI: 0.15-9.53%, P = 0.0434), mitochondria oxidative phosphorylate capacity ( P < 0.0001). Biomolecules spatial distribution in situ and bioinformatic analyses of transcriptomics suggested COPD-related alteration in metabolites and gene expression, which can be impacted by exercise. Conclusion::COPD rat model had multi-level structure and function impairment, which can be mitigated by exercise.